{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-018256","form_type":"8-K","ticker":"LIXT","cik":"0001335105","company_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","filed_at":"2025-07-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.766247+00:00","generated_at":"2026-05-18T09:03:54.977633+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Lixte Biotechnology closes $1.5M registered direct offering of common stock and pre-funded warrants","bullets":["Closed registered direct offering of 974,026 shares (or pre-funded warrants) at $1.54 per share for gross proceeds of ~$1.5M.","Offering comprised 210,675 common shares and pre-funded warrants for 763,351 shares; closed July 8, 2025.","Net proceeds to be used for general corporate purposes and working capital.","Spartan Capital Securities acted as exclusive placement agent; TroyGould PC provided legal counsel."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-018256","json":"https://secwatch.observer/filing/0001641172-25-018256.json","markdown":"https://secwatch.observer/filing/0001641172-25-018256.md","text":"https://secwatch.observer/filing/0001641172-25-018256.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1335105/000164117225018256/0001641172-25-018256-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1335105/000164117225018256/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:03:54.977633+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}